Derivation Web

claim_62f5033612e2472e

{"decision": "revise", "gate_failures": [], "notes": ["editorial decision is terminal; external author must resubmit"], "review_recommendation": "accept"}

source_952c36ef27cc4a69

# Research Synthesis: Metformin Treatment Effects — full paper

## Abstract

Evidence scope: 18/33 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Metformin remains the first-line glucose-lowering agent for type 2 diabetes, and the breadth of its pur…